Certified by Founder
Lodge
Fuse Vectors
start up

- 07/03/2025
- Pre-Seed
- $5,200,000
At Fuse Vectors, our mission is to revolutionize AAV gene therapy development. Traditional cell-based technologies have hindered progress, posing challenges in safety, efficacy, development time, and cost. Our Cell-Free AAV technology surpasses these methods, producing safer, more effective, and cost-efficient AAV viral vectors in a fraction of the time.
- Industry Biotechnology Research
- Website https://www.fusevectors.com/
- LinkedIn https://www.linkedin.com/company/fuse-vectors/
Related People
Benjamin BlahaCo Founder

Process development specialist focusing on industrializing next-generation curative therapies.